Setia Vishwas (CIK 2021256) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-06). Recent activity: Sell MPLT (4,803 shares), Sell MPLT (8,989 shares), Sell MPLT (325 shares), Sell MPLT (787 shares), Sell MPLT (9,935 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 4,803 | $131,410 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 8,989 | $254,209 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 325 | $9,607 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 787 | $23,704 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 9,935 | $279,372 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 968 | $28,072 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 8,496 | $238,228 |
| 2026-05-06 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 2,068 | $60,117 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 2,806 | $75,397 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 29 | $783 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 87 | $2,392 |
| 2026-02-09 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Buy | 7,730 | $0 |
| 2026-01-29 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Sell | 33,382 | $600,208 |
| 2025-10-28 | MapLight Therapeutics, Inc. (MPLT) | Chief Financial Officer | Buy | 43,367 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-06